Investment Risk Analysis: MORPLAN LIMITED

1. Risk Rating: MEDIUM

Justification: While the company remains solvent with positive net assets of £3.73M and benefits from group support, the sustained erosion of the balance sheet (net assets declining approximately 45% over five years), significant cash deterioration, and revenue contraction present material concerns. The group structure and recent acquisition activity provide a partial offset, but the trajectory requires close monitoring.

2. Key Concerns

Concern 1: Sustained Decline in Net Assets

Net assets have fallen from £6.75M (2019) to £3.73M (2024)—a decline of approximately 45% over five years. This persistent erosion of shareholder value suggests the business is consuming rather than generating wealth. The 2024 net assets figure is now below the 2015 level (£3.71M), effectively erasing a decade of accumulated value. With no dividends declared, retained losses are accumulating within shareholders' funds.

Concern 2: Significant Cash Deterioration

Cash has fallen from £1.21M (2023) to £542K (2024)—a 55% year-on-year decline. This follows a pattern of cash volatility (dropping to £40.5K in 2021 before recovering). Against total liabilities of £4.1M, the cash position appears thin. While the strategic report references banking and parent company facilities, the speed of cash depletion raises questions about working capital adequacy and the company's ability to fund operations without external support.

Concern 3: Revenue Contraction and Forward Headwinds

Turnover declined 10.2% from £17.6M (2023) to £15.8M (2024). The directors explicitly note that 2025 will face increased Employer NI contributions, reduced Retail Rates Relief, and higher Minimum Wage—all effective April 2025. Combined with subdued domestic demand expectations, there is a reasonable probability of further revenue pressure and margin compression in the near term.

3. Positive Indicators

Group Support and Strategic Acquisition

Morplan is part of the Raja Group, which acquired Retif (Morplan's former owners) in October 2024. Retif reportedly has ~£100M annual sales and 380,000 retail customers. This provides potential scale benefits in purchasing, distribution, and market access. The group structure also implies potential financial support if required.

Gross Margin Improvement

Despite revenue decline, gross profit improved from 53% to 55% of sales. This demonstrates effective sourcing strategies (shifting away from China, leveraging group buying power) and pricing discipline during a challenging period.

Operational Cost Discipline

Distribution and administrative costs fell by 6.2%, and debtor days improved by 15%. Headcount was reduced from 82 to 79 through efficiency gains rather than redundancies. This indicates active management of the cost base.

Regulatory Compliance and Governance

Accounts are filed on time and audited. The company maintains ISO 9001 and ISO 14001 accreditations. Confirmation statements are current. The receipt of a Royal Warrant from King Charles also suggests operational credibility and quality standards.

4. Due Diligence Notes

Items Requiring Further Investigation:

1. Intercompany Balances and Group Facilities: The strategic report references funding from "its bankers and parent company." The extent of group indebtedness, any related-party balances, and the terms of parent company facilities should be examined. Given the concentrated PSC ownership (>75% held by Ms Kapel-Marcovici), related-party transactions warrant scrutiny.

2. Working Capital Breakdown: The available data does not separately disclose current assets, current liabilities, trade debtors, or trade creditors. Calculating a meaningful current ratio or quick ratio is not possible from the summary data. The full accounts should be examined for working capital composition and any covenant positions on banking facilities.

3. PPE Write-off Trajectory: Over £100K of redundant PPE was written off in 2024, with "further write-offs to come over the next two years." The quantum and timing of these future write-offs should be quantified to assess their impact on future profitability and asset values.

4. Impact of Retif Acquisition: The acquisition of Retif by the Raja Group creates a new dynamic. Understanding the strategic intent, integration costs, and any financial obligations arising from this acquisition is important. It is unclear whether Morplan may bear any portion of acquisition-related costs.

5. Currency Hedging Details: The company sources globally and uses forward contracts to hedge currency risk. The maturity profile, effectiveness, and any mark-to-market exposures on these instruments should be reviewed, particularly given the shift toward Indian sub-continent sourcing.

6. Branch Entity Performance: The Irish Branch entity is noted as a growth area. Understanding its current contribution, losses (if any), and capital commitments would inform the overall risk profile.

7. Store Expansion Deferral: The decision to delay the fifth store opening suggests capital preservation but also signals limited confidence in near-term demand. Any lease commitments or sunk costs related to this delayed expansion should be investigated.